These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7633432)

  • 1. Two novel factor IX promoter mutations: incremental progress towards 'saturation in vivo mutagenesis' of a human promoter region.
    Ketterling RP; Liu JZ; Liao D; Kasper CK; Ambriz R; Paredes R; Sommer SS
    Hum Mol Genet; 1995 Apr; 4(4):769-70. PubMed ID: 7633432
    [No Abstract]   [Full Text] [Related]  

  • 2. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
    Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
    Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usual and unusual mutations in a cohort of Belgian patients with hemophilia B.
    Lannoy N; Lambert C; Farrugia A; Van Damme A; Hermans C
    Thromb Res; 2017 Jan; 149():25-28. PubMed ID: 27865967
    [No Abstract]   [Full Text] [Related]  

  • 4. A mutation in the 3' untranslated region of the factor IX gene in four families with hemophilia B.
    Vielhaber E; Jacobson DP; Ketterling RP; Liu JZ; Sommer SS
    Hum Mol Genet; 1993 Aug; 2(8):1309-10. PubMed ID: 8401514
    [No Abstract]   [Full Text] [Related]  

  • 5. An A to T transversion at position -5 of the factor IX promoter results in hemophilia B.
    Picketts DJ; D'Souza C; Bridge PJ; Lillicrap D
    Genomics; 1992 Jan; 12(1):161-3. PubMed ID: 1733855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single base pair deletion in the promoter region of the factor IX gene is associated with haemophilia B.
    Hall AJ; Chuansumrit A; Peake IR; Winship PR
    Thromb Haemost; 1994 Dec; 72(6):799-803. PubMed ID: 7740444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-four novel hemophilia B mutations revealed by rapid scanning of the whole factor IX gene in a French population sample.
    Ghanem N; Costes B; Martin J; Vidaud M; Rothschild C; Foyer-Gazengel C; Goossens M
    Eur J Hum Genet; 1993; 1(2):144-55. PubMed ID: 8055323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter region.
    Royle G; Van de Water NS; Berry E; Ockelford PA; Browett PJ
    Br J Haematol; 1991 Feb; 77(2):191-4. PubMed ID: 2004020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A less severe form of Haemophilia B Leyden.
    Crossley M; Winship PR; Austen DE; Rizza CR; Brownlee GG
    Nucleic Acids Res; 1990 Aug; 18(15):4633. PubMed ID: 2388855
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene.
    Wulff K; Bykowska K; Lopaciuk S; Herrmann FH
    Acta Biochim Pol; 1999; 46(3):721-6. PubMed ID: 10698280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel human pathological mutations. Gene symbol: F9. Disease: Haemophilia B.
    Niazi G; Shaukat Z; Masood K; Hussain R
    Hum Genet; 2009 Aug; 126(2):332. PubMed ID: 19693996
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemophilia B Liverpool: a new British family with mild haemophilia B associated with a -6 G to A mutation in the factor IX promoter.
    Stowell KM; Figueiredo MS; Brownlee GG; Jones P; Bolton-Maggs PH
    Br J Haematol; 1993 Sep; 85(1):188-90. PubMed ID: 8251390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new case of severe hemophilia B Leyden, associated with a G to C mutation at position -6 of the factor IX promoter.
    Nguyen P; Cornillet P; Potron G
    Am J Hematol; 1995 Jul; 49(3):259-60. PubMed ID: 7604825
    [No Abstract]   [Full Text] [Related]  

  • 14. Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype).
    Reitsma PH; Mandalaki T; Kasper CK; Bertina RM; Briët E
    Blood; 1989 Feb; 73(3):743-6. PubMed ID: 2917196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophilia B Leyden and once mysterious cis-regulatory mutations.
    Funnell AP; Crossley M
    Trends Genet; 2014 Jan; 30(1):18-23. PubMed ID: 24138812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilia B Leyden: the effect of mutations at position +13 on the liver-specific transcription of the factor IX gene.
    Reijnen MJ; Maasdam D; Bertina RM; Reitsma PH
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):341-8. PubMed ID: 8075306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The putative factor IX gene promoter in hemophilia B Leyden.
    Reitsma PH; Bertina RM; Ploos van Amstel JK; Riemens A; Briët E
    Blood; 1988 Sep; 72(3):1074-6. PubMed ID: 3416069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biology of hemophilia B.
    Roberts HR
    Thromb Haemost; 1993 Jul; 70(1):1-9. PubMed ID: 8236083
    [No Abstract]   [Full Text] [Related]  

  • 19. Five novel factor IX mutations in unrelated hemophilia B families.
    Chen SH; Schoof JM; Scott CR; Thompson AR
    Hum Mol Genet; 1993 May; 2(5):599-600. PubMed ID: 8518801
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.